The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation
Radiotherapy and Oncology. 1989;16(2):121-128 
Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor–alpha
Cancer. 1993;72(3):809-818
Cisplatin (cis-diamminedichloroplatinum II)
Cancer Treatment Reviews. 1979;6(1):17-39
cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment
Biochemical Pharmacology. 1986;35(4):607-611
Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer
Lung Cancer. 1991;7(4):276
In vivo crosslinking of nuclear proteins to DNA by cis-diamminedichloroplatinum (II) in differentiating rat myoblasts
Experimental Cell Research. 1989;183(2):376-387
Analysis of Histopathology of the Irradiated Adult Rat Brain During First 3 Post-Irradiation Months: Expression of Protein Kinase C and the Role of Apoptosis in Radiation Encephalopathy
The Ewha Medical Journal. 1995;18(4):323
Experimental Studies of Cis-Diamminedichloroplatinum (II) and Cis-Diammine-1, 1-Cyclobutandicarboxylate Platinum (II) Combination Therapy for Malignant Gynecologic Tumors
Asia-Oceania Journal of Obstetrics and Gynaecology. 2010;19(4):467-476
Analysis of the Histopathology of the Irradiated Rat Brain with or Without Cisplatin in the First Post-Irradiation Month
The Ewha Medical Journal. 1995;18(3):169
DNA degradation after interaction of cis- and trans-diamminedichloroplatinum (II) with calf thymus nuclei
Molecular Biology Reports. 1986;11(1):25-28
